Risk factors associated with myocardial infarction in venous thromboembolism patients
Laliberté, F, Nutescu, E A, Lefebvre, P, Rondeau-Leclaire, J, Bookhart, B K, LaMori, J C, Damaraju, C V, Schein, J, Kaatz, S
Published in Current medical research and opinion (01.01.2014)
Published in Current medical research and opinion (01.01.2014)
Get more information
Journal Article
Prior myocardial infarction and presence of upper gastrointestinal conditions among patients with venous thromboembolism: prevalence, associated comorbidities and burden
LaMori, J., Gross, H. J., DiBonaventura, M., Bookhart, B. K., Schein, J.
Published in Journal of clinical pharmacy and therapeutics (01.06.2014)
Published in Journal of clinical pharmacy and therapeutics (01.06.2014)
Get full text
Journal Article
In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty
Vekeman, F, LaMori, J C, Laliberté, F, Nutescu, E, Duh, M S, Bookhart, B K, Schein, J, Dea, K, Olson, W H, Lefebvre, P
Published in Journal of medical economics (01.08.2012)
Published in Journal of medical economics (01.08.2012)
Get more information
Journal Article
Hematologic and transfusion outcomes following implementation of the erythropoiesis-stimulating agent (ESA) National Coverage Determination (NCD) in Medicare cancer patients receiving chemotherapy
Gilmore, J., Feinberg, B. A., Gondesen, T., Jackson, J., Bookhart, B. K., McKenzie, R. S.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Transfusion outcomes among oncology patients initiated with erythropoiesis-stimulating agents (ESAs) at baseline (BL) hemoglobin (Hb) of <10 versus 10–11g/dL: Observational data from the dosing and outcomes study of erythropoiesis-stimulating therapies (DOSE) registry
Burton, T., Larholt, K., Pashos, C. L., Peake, C., Bookhart, B. K., Corral, M., Piech, C. T., McKenzie, R. S.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Transfusion outcomes in erythropoiesis-stimulating agent (ESA)-treated cancer chemotherapy patients based on achieved hemoglobin (Hb) levels
Larholt, K., Burton, T., Hoaglin, D., Pashos, C. L., Bookhart, B. K., Corral, M., Piech, C. T., McKenzie, R. S.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1
Donga, Prina, Emond, Bruno, Rossi, Carmine, Bookhart, Brahim K, Lee, Johnnie, Caron-Lapointe, Gabrielle, Wei, Fangzhou, Lafeuille, Marie-Hélène
Published in ClinicoEconomics and outcomes research (01.01.2023)
Published in ClinicoEconomics and outcomes research (01.01.2023)
Get full text
Journal Article
PCV37 - Health Care Costs among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin
Deitelzweig, S, Laliberté, F, Raut, R, Germain, G, Bookhart, BK, Olson, WH, Schein, J, Lefebvre, P
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article
Health Care Costs among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin
Deitelzweig, S, Laliberté, F, Raut, R, Germain, G, Bookhart, BK, Olson, WH, Schein, J, Lefebvre, P
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article